Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis

Some commonly available patient or disease characteristics may be associated with progression-free survival (PFS) and overall survival (OS) in EGFR-mutant non-small cell lung cancer (NSCLC) patients receiving EGFR-TKIs (epidermal growth factor receptor - tyrosine kinase inhibitors). We performed a s...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancers (Basel)
Glavni autori: Buonerba, Carlo, Iaccarino, Simona, Dolce, Pasquale, Pagliuca, Martina, Izzo, Michela, Scafuri, Luca, Costabile, Ferdinando, Riccio, Vittorio, Ribera, Dario, Mucci, Brigitta, Carrano, Simone, Picozzi, Fernanda, Bosso, Davide, Formisano, Luigi, Bianco, Roberto, De Placido, Sabino, Di Lorenzo, Giuseppe
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2019
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6770537/
https://ncbi.nlm.nih.gov/pubmed/31466227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11091259
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items